For Ozempic (diabetes dosing), nausea affects approximately 15-20% of patients, while Wegovy (weight management dosing) has higher rates of nausea (up to 44%) and constipation (approximately 24%)
Frequently Asked Questions (FAQ) on Mixing Peptide BPC 157 What is BPC 157, and why is it used in research
These are key markers of systemic inflammation associated with cardiovascular disease and metabolic disorders
Clinic Support: GoldyZ is an aesthetic clinic where our doctors provide free guidance on product usage and suitability
Understanding your genetic peptide profile helps PlexusDx personalize your treatment approach beyond just dose selection
Contact your GP if you experience severe or persistent vomiting or diarrhoea, signs of dehydration, severe abdominal pain, difficulty swallowing, blood in stools, or worsening diabetes control